Hepatorenalt syndrom: diagnose, behandling og forebyggelse

Mads Egerod Israelsen; Lise Lotte Gluud; Flemming Bendtsen; Søren Møller; Aleksander Ahm Krag

Hepatorenalt syndrom: diagnose, behandling og forebyggelse

Translated title of the contribution: Hepatorenal syndrome: diagnosis, treatment and prevention

Mads Egerod Israelsen, Lise Lotte Gluud, Flemming Bendtsen, Søren Møller, Aleksander Ahm Krag

1 Citation (Scopus)

Abstract

Cirrhosis, ascites and renal impairment are associated with high morbidity and mortality. The hepatorenal syndrome (HRS) is a type of renal failure that affects patients with cirrhosis and ascites. This paper provides an update on evidence-based interventions in HRS. A number of factors can precipitate HRS. The monitoring, prevention, early detection, and correct treatment of these are essential. Terlipressin combined with albumin is the first-line treatment of type 1 HRS. In type 2 HRS with refractory ascites, liver transplantation and TIPS should be considered.

Translated title of the contribution	Hepatorenal syndrome: diagnosis, treatment and prevention
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	175
Issue number	22
Pages (from-to)	1562-6
Number of pages	5
ISSN	0041-5782
Publication status	Published - 27 May 2013

Access to Document

http://ugeskriftet.dk/videnskab/hepatorenalt-syndrom-diagnose-behandling-og-forebyggelse

Cite this

@article{35dc1199bf1944e7849aa33f07b6f6fd,

title = "Hepatorenalt syndrom: diagnose, behandling og forebyggelse",

abstract = "Cirrhosis, ascites and renal impairment are associated with high morbidity and mortality. The hepatorenal syndrome (HRS) is a type of renal failure that affects patients with cirrhosis and ascites. This paper provides an update on evidence-based interventions in HRS. A number of factors can precipitate HRS. The monitoring, prevention, early detection, and correct treatment of these are essential. Terlipressin combined with albumin is the first-line treatment of type 1 HRS. In type 2 HRS with refractory ascites, liver transplantation and TIPS should be considered.",

keywords = "Albumins, Ascites, Drug Therapy, Combination, Evidence-Based Medicine, Hepatorenal Syndrome, Humans, Kidney, Liver Cirrhosis, Liver Transplantation, Lypressin, Portasystemic Shunt, Transjugular Intrahepatic, Vasoconstrictor Agents",

author = "\{Egerod Israelsen\}, Mads and Gluud, \{Lise Lotte\} and Flemming Bendtsen and S{\o}ren M{\o}ller and Krag, \{Aleksander Ahm\}",

year = "2013",

month = may,

day = "27",

language = "Dansk",

volume = "175",

pages = "1562--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "22",

}

TY - JOUR

T1 - Hepatorenalt syndrom: diagnose, behandling og forebyggelse

AU - Egerod Israelsen, Mads

AU - Gluud, Lise Lotte

AU - Bendtsen, Flemming

AU - Møller, Søren

AU - Krag, Aleksander Ahm

PY - 2013/5/27

Y1 - 2013/5/27

N2 - Cirrhosis, ascites and renal impairment are associated with high morbidity and mortality. The hepatorenal syndrome (HRS) is a type of renal failure that affects patients with cirrhosis and ascites. This paper provides an update on evidence-based interventions in HRS. A number of factors can precipitate HRS. The monitoring, prevention, early detection, and correct treatment of these are essential. Terlipressin combined with albumin is the first-line treatment of type 1 HRS. In type 2 HRS with refractory ascites, liver transplantation and TIPS should be considered.

AB - Cirrhosis, ascites and renal impairment are associated with high morbidity and mortality. The hepatorenal syndrome (HRS) is a type of renal failure that affects patients with cirrhosis and ascites. This paper provides an update on evidence-based interventions in HRS. A number of factors can precipitate HRS. The monitoring, prevention, early detection, and correct treatment of these are essential. Terlipressin combined with albumin is the first-line treatment of type 1 HRS. In type 2 HRS with refractory ascites, liver transplantation and TIPS should be considered.

KW - Albumins

KW - Ascites

KW - Drug Therapy, Combination

KW - Evidence-Based Medicine

KW - Hepatorenal Syndrome

KW - Humans

KW - Kidney

KW - Liver Cirrhosis

KW - Liver Transplantation

KW - Lypressin

KW - Portasystemic Shunt, Transjugular Intrahepatic

KW - Vasoconstrictor Agents

UR - https://www.scopus.com/pages/publications/84878735942

M3 - Tidsskriftartikel

C2 - 23721840

SN - 0041-5782

VL - 175

SP - 1562

EP - 1566

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 22

ER -

Hepatorenalt syndrom: diagnose, behandling og forebyggelse

Abstract

Access to Document

Other files and links

Fingerprint

Cite this